BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 31433414)

  • 1. Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in S. chinensis in treating Alzheimer's disease using UPLC-Q-TOF-MS.
    Wei M; Liu Z; Liu Y; Li S; Hu M; Yue K; Liu T; He Y; Pi Z; Liu Z; Song F
    Food Funct; 2019 Sep; 10(9):5656-5668. PubMed ID: 31433414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic and urinary metabolomics studies on the mechanism of Schisandra polysaccharide in the treatment of Alzheimer's disease.
    Liu Y; Liu Z; Wei M; Hu M; Yue K; Bi R; Zhai S; Pi Z; Song F; Liu Z
    Food Funct; 2019 Jan; 10(1):432-447. PubMed ID: 30623955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematically Characterize the Anti-Alzheimer's Disease Mechanism of Lignans from
    Wei M; Liu Y; Pi Z; Li S; Hu M; He Y; Yue K; Liu T; Liu Z; Song F; Liu Z
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated strategy using LC-MS/MS combined with
    Fu J; Zhang H; Liu S; Wu J; Zhang Y; Gao Y; Song F; Qin Y; Hu X; Liu Z
    Food Funct; 2021 Oct; 12(19):8932-8945. PubMed ID: 34606559
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic mapping of Schisandra chinensis lignans and their metabolites in rats using a metabolomic approach based on HPLC with quadrupole time-of-flight MS/MS spectrometry.
    Wang J; Jiang B; Shan Y; Wang X; Lv X; Mohamed J; Li H; Wang C; Chen J; Sun J
    J Sep Sci; 2020 Jan; 43(2):378-388. PubMed ID: 31625256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A UPLC-TOF/MS-based metabolomics study of rattan stems of Schisandra chinensis effects on Alzheimer's disease rats model.
    Yang BY; Tan JY; Liu Y; Liu B; Jin S; Guo HW; Kuang HX
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28664556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and metabolomics approach based on UHPLC-MS to evaluate therapeutic effect of lignans from S. Chinensis in alzheimer's disease.
    Zhou Y; Wei M; Fan M; Liu Z; Wang A; Liu Y; Men L; Pi Z; Liu Z; Song F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jul; 1178():122859. PubMed ID: 34274605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetic study of the components in Alpinia oxyphylla Miq.-Schisandra chinensis (Turcz.) Baill. herb pair and its single herb between normal and Alzheimer's disease rats by UPLC-MS/MS.
    Qi Y; Cheng X; Jing H; Yan T; Xiao F; Wu B; Bi K; Jia Y
    J Pharm Biomed Anal; 2020 Jan; 177():112874. PubMed ID: 31542420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in normal and insomniac rats brain microdialysates and homogenate samples: towards an in-depth study for its sedative-hypnotic activity.
    Wei B; Li Q; Fan R; Su D; Ou X; Chen K; Chen X; Jia Y; Bi K
    J Mass Spectrom; 2013 Apr; 48(4):448-58. PubMed ID: 23584938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated strategy for ascertaining quality marker of Schisandra chinensis (Turcz.) Baill based on correlation analysis between depression-related monoaminergic metabolites and chemical components profiling.
    Zhang Y; Lv X; Liu R; Zhang M; Liu H; Gao H; Zhang Q; Xu H; Li Q; Bi K
    J Chromatogr A; 2019 Aug; 1598():122-131. PubMed ID: 31047662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on Urine Metabolic Profile of Aβ25-35-Induced Alzheimer's Disease Using UHPLC-Q-TOF-MS.
    Liu Y; Wei M; Yue K; Hu M; Li S; Men L; Pi Z; Liu Z; Liu Z
    Neuroscience; 2018 Dec; 394():30-43. PubMed ID: 30316910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated study on the comprehensive mechanism of
    Fu J; Li J; Sun Y; Liu S; Song F; Liu Z
    Food Funct; 2023 Jan; 14(2):734-745. PubMed ID: 36562313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in rat plasma and its application to a comparative pharmacokinetic study in normal and insomnic rats.
    Wei B; Li Q; Su D; Fan R; Zhao L; Geng L; He B; Chen X; Jia Y; Bi K
    J Pharm Biomed Anal; 2013 Apr; 77():120-7. PubMed ID: 23416367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-dependent pharmacokinetics of lignans in rats after single and multiple oral administration of Schisandra chinensis extract.
    Xu H; Gan J; Liu X; Wu R; Jin Y; Li M; Yuan B
    J Ethnopharmacol; 2013 May; 147(1):224-31. PubMed ID: 23501155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain.
    Wei BB; Liu MY; Chen ZX; Wei MJ
    Acta Pharmacol Sin; 2018 Apr; 39(4):616-625. PubMed ID: 29323336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.
    Sun JH; Liu X; Cong LX; Li H; Zhang CY; Chen JG; Wang CM
    Lipids Health Dis; 2017 Aug; 16(1):145. PubMed ID: 28764799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometry-based urinary metabolomics for exploring the treatment effects of Radix ginseng-Schisandra chinensis herb pair on Alzheimer's disease in rats.
    Wang A; Pi Z; Liu S; Zheng Z; Liu Z; Song F
    J Sep Sci; 2021 Aug; 44(16):3158-3166. PubMed ID: 34110709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
    Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
    J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explore the effects of Huang-Lian-Jie-Du-Tang on Alzheimer's disease by UPLC-QTOF/MS-based plasma metabolomics study.
    Sun LM; Zhu BJ; Cao HT; Zhang XY; Zhang QC; Xin GZ; Pan LM; Liu LF; Zhu HX
    J Pharm Biomed Anal; 2018 Mar; 151():75-83. PubMed ID: 29310050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification.
    Wu Z; Jia M; Zhao W; Huang X; Yang X; Chen D; Qiaolongbatu X; Li X; Wu J; Qian F; Lou Y; Fan G
    J Ethnopharmacol; 2022 May; 289():115031. PubMed ID: 35091014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.